Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002525 · ClinicalTrials.gov registry record · Phase 3
Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed
A Phase 3 study, sponsored by ECOG-ACRIN Cancer Research Group.
- Terminated
- Registry status
- Phase 3
- Development phase
- 859
- Enrollment target
NCT00002525 is a Phase 3 study that was terminated before completion, run by ECOG-ACRIN Cancer Research Group. The registered enrollment target is 859 participants.
The verdict
NCT00002525, a Phase 3 study, was terminated before completion, sponsored by ECOG-ACRIN Cancer Research Group.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 859 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving drugs in different ways may kill more tumor cells. It is not yet known if surgery is more effective with or without chemotherapy for colon cancer. PURPOSE: Randomized phase III trial to evaluate whether perioperative 5-Fluorouracil (5-FU) chemotherapy after curative resection could improve overall survival and disease-free survival in patients with Duke's B3 or C colon cancer.
Interventions
- DRUG fluorouracil
- DRUG leucovorin calcium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 859 participants |
| Start Date | 1993-10-01 |
| Est. Completion | 2015-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002525
The ClinicalTrials.gov registry entry for NCT00002525 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 859 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ECOG-ACRIN Cancer Research Group, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which fluorouracil is the first listed.
NCT00002525 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002525 about?
NCT00002525 is a clinical study titled "Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving drugs in different ways may kill more tumor cells. It is not yet known if surgery is more effective with or without chemotherapy for colon c...
What is the current status of trial NCT00002525?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 859 participants. The study started on 1993-10-01. Estimated completion is 2015-04.
What interventions are being tested in trial NCT00002525?
The interventions under investigation include: fluorouracil (DRUG), leucovorin calcium (DRUG).
Who is sponsoring clinical trial NCT00002525?
This trial is sponsored by ECOG-ACRIN Cancer Research Group, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.